|
|
|
| home > white papers > Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs - World Courier |
|
|
 WHITE PAPERS |
|
World Courier
|
|
Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs
|
|
With a fully integrated GxP-compliant transport, storage and distribution system in place and over 140 wholly owned ISO 9001 - certified offices in more than 50 countries, WORLD COURIER, an AmerisourceBergen® company, is the world’s largest and most experienced provider of specialty courier services. It is uniquely positioned to meet the most demanding industry requirements for managing the global distribution of time - and temperaturesensitive pharmaceutical products and IMPs used commercially or in clinical trials.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
PCI Pharma Services Announces Serialization Installation at Tredegar Manufacturing Center of Excellence
PCI
Pharma Services (PCI) is pleased to announce the installation and validation of
its latest comprehensive Serialization system, located at its manufacturing Center
of Excellence in Tredegar, UK. The investment
demonstrates PCI’s continued investment in and expansion of market-leading
Serialization capabilities. This latest installation increases PCI’s
Serialization capability to support clients in advance of implementation dates for
the European Falsified Medicines Directive (EU FMD), as well as supply for the
US and emerging markets, including countries such as China, Turkey, Brazil,
Saudi Arabia and others. PCI’s system is
compliant to all EU member country requirements for Serialization and
specialized labeling, including application and integration of advanced
Anticounterfeiting technologies.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Russia Orange Paper: 1st Quarter 2014
Synergy Research Group
In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia:
1. Fast patient enrollment due to the centralized medical infrastructure.
2. Nearly 100% patient retention
3. GCP trained and certified Investigative Sites generating high quality data
4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >> |
|
 |
Industry Events |
 |
Pharmaceutical Packaging and Device Labelling Europe
11-12 September 2018, Munich, Germany
Relaunching
the event after a three year hiatus, Pharma Packaging and Labelling Europe is
back to deliver key, actionable insight on the very latest regulatory
requirements, technological innovations, strategic developments, and how to
implement them into your packaging and labelling chain with both maximum
efficiency and minimal cost. The conference is packed with thought provoking
innovative discussions.
More info >> |
|
|
|
